Next Article in Journal
Options and Obstacles for Designing a Universal Influenza Vaccine
Next Article in Special Issue
Mechanisms of HIV Protein Degradation into Epitopes: Implications for Vaccine Design
Previous Article in Journal
European Bats as Carriers of Viruses with Zoonotic Potential
Previous Article in Special Issue
Pseudo-Mannosylated DC-SIGN Ligands as Potential Adjuvants for HIV Vaccines
Open AccessReview

Challenges in Mucosal HIV Vaccine Development: Lessons from Non-Human Primate Models

Vaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
Author to whom correspondence should be addressed.
Viruses 2014, 6(8), 3129-3158;
Received: 10 June 2014 / Revised: 21 July 2014 / Accepted: 23 July 2014 / Published: 15 August 2014
(This article belongs to the Special Issue AIDS Vaccine 2014)
An efficacious HIV vaccine is urgently needed to curb the AIDS pandemic. The modest protection elicited in the phase III clinical vaccine trial in Thailand provided hope that this goal might be achieved. However, new approaches are necessary for further advances. As HIV is transmitted primarily across mucosal surfaces, development of immunity at these sites is critical, but few clinical vaccine trials have targeted these sites or assessed vaccine-elicited mucosal immune responses. Pre-clinical studies in non-human primate models have facilitated progress in mucosal vaccine development by evaluating candidate vaccine approaches, developing methodologies for collecting and assessing mucosal samples, and providing clues to immune correlates of protective immunity for further investigation. In this review we have focused on non-human primate studies which have provided important information for future design of vaccine strategies, targeting of mucosal inductive sites, and assessment of mucosal immunity. Knowledge gained in these studies will inform mucosal vaccine design and evaluation in human clinical trials. View Full-Text
Keywords: HIV vaccine; mucosal immunity; non-human primate HIV vaccine; mucosal immunity; non-human primate
MDPI and ACS Style

Tuero, I.; Robert-Guroff, M. Challenges in Mucosal HIV Vaccine Development: Lessons from Non-Human Primate Models. Viruses 2014, 6, 3129-3158.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Search more from Scilit
Back to TopTop